Peter Fedichev to End Age-Related Diseases in 2019
We are continuing to release the talks from Ending Age Related Diseases 2019, a highly successful two-day event that brought together leading researchers and investors to discuss the future aging and rejuvenation.
Dr. Peter Fedichev (co-founder of GERO) discussed biomarkers within the context of mouse studies, focusing on physiological frailty, blood cell counts, and other factors. He explained in detail the Dynamic frailty index and its advantages over other frailty models, such as epigenetic clocks. He explained the differences between mice and humans, notably that interventions that are effective in mice may not be applicable to humans.